Calidi Biotherapeutics Inc (CLDI)
0.2288
-0.01
(-4.15%)
USD |
NYAM |
May 24, 16:00
0.2299
0.00 (0.00%)
After-Hours: 05:26
Calidi Biotherapeutics Cash from Operations (Quarterly): -3.831M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -3.831M |
| December 31, 2023 | -5.186M |
| September 30, 2023 | -10.41M |
| Date | Value |
|---|---|
| March 31, 2023 | -3.107M |
| September 30, 2022 | -9.338M |
| September 30, 2021 | -5.029M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-10.41M
Minimum
Sep 2023
-3.107M
Maximum
Mar 2023
-6.150M
Average
-5.108M
Median
Cash from Operations (Quarterly) Benchmarks
| Minerva Neurosciences Inc | -6.094M |
| Viking Therapeutics Inc | -6.134M |
| CytomX Therapeutics Inc | -26.04M |
| Genprex Inc | -5.298M |
| Janux Therapeutics Inc | -14.84M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.005M |
| Cash from Financing (Quarterly) | 3.013M |
| Free Cash Flow | -22.68M |
| Free Cash Flow Per Share (Quarterly) | -0.1079 |
| Free Cash Flow Yield | -326.9% |